Q3 2018 EPS Estimates for Hologic, Inc. (HOLX) Raised by Jefferies Group

Lester Mason
November 15, 2017

Hologic Inc. (NASDAQ:HOLX) updated its FY17 earnings guidance on Wednesday.

The company had seen its current volume reaching at 0.92 million shares in the last trade. Gabelli also issued estimates for Hologic's FY2019 earnings at $2.35 EPS, FY2020 earnings at $2.60 EPS and FY2021 earnings at $2.95 EPS.

Several research analysts have recently commented on HOLX shares. Canaccord Genuity maintained it with "Buy" rating and $48.0 target in Monday, September 25 report. Hologic, Inc. has had 11 insider trades in the last 3 months, including 0 open market buys and 11 sells. (NASDAQ:HOLX) had an excellent day at the stock market, with its price going up by -1.72%, to $38.97. Deutsche Bank AG cut their price objective on shares of Hologic from $51.00 to $49.00 and set a "buy" rating for the company in a report on Thursday, August 3rd. Legal General Group Inc Public Ltd Com holds 11,264 shares or 0% of its portfolio.

October 10 investment analysts at Jefferies Group LLC made no change to the company rating of "Buy" with a current price target of $44.00. Stifel Nicolaus upgraded the shares of HOLX in report on Friday, December 11 to "Buy" rating. First Houston Capital Inc acquired 9,200 shares as Hologic Inc (HOLX)'s stock rose 7.50%.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, November 8th. When looking at the past five sessions, the stock returned -1.49% losses and is down by -5.66% compared with its 200-day moving average of $41.25. The year to date performance is at -2.87% with a 52 week high of -16.73% and a 52 week low of 8.98%. Kahn Brothers Group Inc who had been investing in Hologic for a number of months, seems to be less bullish one the $11.11B market cap company. The medical equipment provider reported $0.50 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.49 by $0.01. The firm had revenue of $802.90 million during the quarter, compared to analysts' expectations of $792.54 million. Hologic had a return on equity of 21.69% and a net margin of 24.70%. The stock's 52-week range is $35.76 to $46.80, and its 3-month range is $35.76 to $40.70. The medical equipment provider reported $0.50 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.49 by $0.01.

In related news, VP Karleen Marie Oberton sold 31,470 shares of the business's stock in a transaction that occurred on Monday, October 10th. The company shares sank -44.95% from their peak of $ 15.35 and now has a $564.12 million market value of equity. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lawrence M. Levy sold 7,139 shares of the business's stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $36.81, for a total value of $353,228.76. Institutional investors own 96.41% of the company's stock. The disclosure for this sale can be found here. The stock declined 0.03% or $0.01 reaching $39.61 on the news.

These firms have modified their investment in HOLX. Olstein Capital Management, L.p. now controls 119,700 shares worth $4,392,000. AQR Capital Management LLC increased its position in shares of Hologic by 56.1% in the second quarter. Dimensional Fund Advisors Lp augmented its stake by buying 105,360 shares an increase of 5.7% in the quarter. Grove Bank & Trust increased its holdings in Hologic by 115.8% in the third quarter. Following the completion of the transaction, the vice president now directly owns 9,406 shares in the company, valued at approximately $369,561.74. Of those holders, 240 had increased positions amounting to 42.37 million shares, 253 had decreased positions amounting to 41.71 million shares, and 63 holders have a held position accounting for 186.05 million shares. Finally, National Asset Management Inc. bought a new stake in Hologic in the second quarter worth $203,000. State Street Corp now owns 10,579,925 shares of the company's stock valued at $366,073,000 after buying an additional 284,089 shares in the last quarter.

Other reports by Iphone Fresh

Discuss This Article